Literature DB >> 27131854

Influence of the New Cooperative Medical Scheme on hospitalization cost of patients with nephrotic syndrome in rural China.

Suping Zhang1, Yi Wang1, Wenlu Guo1, Xiangdong Yang2, Zhao Hu2, Tao Peng3.   

Abstract

INTRODUCTION: Rural residents are benefitting from the current New Cooperative Medical Scheme (NCMS) in China. Treatment of diseases has improved and the total cost of hospitalization has decreased significantly because of the application of NCMS. Most articles in this area have mainly focused on the policy of NCMS, but few studies have been relevant to the influence of NCMS on a specific disease and the cost. In the present study, the impact of NCMS on hospitalization costs of patient with nephrotic syndrome from the countryside was investigated and discussed.
METHODS: Three hundred and ninety patients from China and with nephrotic syndrome were enrolled into the present study and were divided into two groups according to whether they had joined the NCMS. The total hospitalization cost, check cost (such as laboratory testing and ultrasound), drugs cost, length of stay in hospital and ratio of renal biopsy in all patients were analyzed.
RESULTS: The expenses for individuals decreased significantly in patients who were part of the NCMS, in contrast with the patients without the NCMS (p<0.001). The ratio of renal biopsy increased significantly in patients who were part of the NCMS (p<0.01). There was no significant difference in cost and length of stay between the two groups.
CONCLUSIONS: The NCMS contributes to reducing personal expenses and therapy of disease.

Entities:  

Keywords:  Asia; Medical; Public Health

Mesh:

Year:  2016        PMID: 27131854

Source DB:  PubMed          Journal:  Rural Remote Health        ISSN: 1445-6354            Impact factor:   1.759


  1 in total

1.  Effectiveness evaluation of quota payment for specific diseases under global budget: a typical provider payment system reform in rural China.

Authors:  Hao-Miao Li; Ying-Chun Chen; Hong-Xia Gao; Yan Zhang; Liangkai Chen; Jing-Jing Chang; Dai Su; Shi-Han Lei; Di Jiang; Xiao-Mei Hu
Journal:  BMC Health Serv Res       Date:  2018-08-13       Impact factor: 2.655

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.